Ophthalmologists and researchers working on retinal regeneration struggle to keep up with the latest studies and clinical trials. A centralized database would aggregate papers, trial results, and treatment protocols.
The platform would include search functionality, filters, and annotations to help users find relevant information quickly.
Research institutions and pharmaceutical companies would pay for access to curated data.
The MVP could focus on aggregating and indexing papers from PubMed.
The biggest challenge is ensuring comprehensive coverage of the field.